Cary Street Partners Investment Advisory’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.5K Sell
453
-30
-6% -$2.1K 0.01% 638
2026
Q1
$36.4K Sell
483
-40
-8% -$2.85K 0.01% 572
2025
Q4
$32.3K Buy
523
+93
+22% +$5.47K 0.01% 557
2025
Q3
$25.2K Buy
430
+112
+35% +$6.53K 0.01% 494
2025
Q2
$18.5K Buy
318
+29
+10% +$1.64K 0.01% 490
2025
Q1
$14.4K Buy
+289
New +$14.8K 0.01% 463
2023
Q4
Sell
-113
Closed -$6.98K 1409
2023
Q3
$6.98K Buy
113
+2
+2% +$127 ﹤0.01% 1391
2023
Q2
$6.55K Buy
111
+39
+54% +$2.48K ﹤0.01% 1340
2023
Q1
$5.32K Sell
72
-213
-75% -$16.4K ﹤0.01% 1310
2022
Q4
$20.8K Buy
+285
New +$22.5K ﹤0.01% 966

Other funds holding NTR

Cary Street Partners Investment Advisory's NTR Position: Q2 2026 in Review

Cary Street Partners Investment Advisory reduced its Nutrien (NTR) stake by 6.2% in Q2 2026, selling an estimated $2.1K and leaving 453 shares worth $28.5K. The position accounts for 0.01% of the portfolio, ranked #638.

Cary Street Partners Investment Advisory first reported a position in NTR in Q4 2022 and has held it in 10 quarters since. The position peaked at $36.4K in Q1 2026. 374 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Cary Street Partners Investment Advisory held 453 shares of Nutrien worth $28.5K as of Q2 2026.
  • Cary Street Partners Investment Advisory sold 30 Nutrien shares in Q2 2026, an estimated $2.1K.
  • Nutrien made up 0.01% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #638 holding.
  • Cary Street Partners Investment Advisory first reported a position in Nutrien in Q4 2022 and has held it in 10 quarters since.
  • Cary Street Partners Investment Advisory's Nutrien position peaked at $36.4K in Q1 2026.
  • 374 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.